{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T01:00:27Z","timestamp":1769821227437,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-024-04673-0","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T05:02:19Z","timestamp":1722920539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Co-occurrence of oral pemphigus vulgaris and herpes simplex virus infection in a young patient with Crohn\u2019s disease: report of a rare case of oral lesions during anti-TFN alpha and immunomodulator therapy"],"prefix":"10.1007","volume":"39","author":[{"given":"Danielle Nobre","family":"Lopes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00eamia Pereira","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla Cristina","family":"de Campos Augusto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrianna","family":"Milagres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Luiza","family":"Miguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arley Silva","family":"Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle Castex","family":"Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin Soares","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcia Henriques","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafaela Elvira","family":"Rozza-de-Menezes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"4673_CR1","doi-asserted-by":"crossref","unstructured":"Kridin K, Schmidt E (2021) Epidemiology of pemphigus. JID Innov 1(1)","DOI":"10.1016\/j.xjidi.2021.100004"},{"key":"4673_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1590\/abd1806-4841.20199011","volume":"94","author":"AM Porro","year":"2019","unstructured":"Porro AM, Seque CA, Ferreira MCC (2019) Enokihara MMS e S. Pemphigus vulgaris An Bras Dermatol 94:264\u2013278","journal-title":"Pemphigus vulgaris An Bras Dermatol"},{"key":"4673_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jaad.2018.02.021","volume":"82","author":"DF Murrell","year":"2020","unstructured":"Murrell DF, Pe\u00f1a S, Joly P, Marinovic B, Hashimoto T, Diaz LA et al (2020) Diagnosis and management of pemphigus: recommendations of an international panel of experts. J Am Acad Dermatol 82:575-585.e1","journal-title":"J Am Acad Dermatol"},{"key":"4673_CR4","unstructured":"Pile HD, Yarrarapu SNS, Crane JS (2023) Drug induced pemphigus. In: StatPearls.\u00a0StatPearls Publishing,\u00a0Treasure Island (FL)"},{"key":"4673_CR5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jaad.2005.01.106","volume":"52","author":"K Yoshida","year":"2005","unstructured":"Yoshida K, Takae Y, Saito H, Oka H, Tanikawa A, Amagai M et al (2005) Cutaneous type pemphigus vulgaris: a rare clinical phenotype of pemphigus. J Am Acad Dermatol 52:839\u2013845","journal-title":"J Am Acad Dermatol"},{"key":"4673_CR6","doi-asserted-by":"crossref","unstructured":"Casuriaga Lamboglia AL, Minut Gubitosi A, Guebenli\u00e1n Bakerdjian C, Giachetto Larraz G (2018) P\u00e9nfigo vulgar en pediatr\u00eda a prop\u00f3sito de un caso. Rev Chil Pediatr 89(5):650\u2013654","DOI":"10.4067\/S0370-41062018005000708"},{"key":"4673_CR7","doi-asserted-by":"crossref","unstructured":"Hertl M, Jedlickova H, Karpati S, Marinovic B, Uzun S, Yayli S et al (2015) Pemphigus. S2 guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol 29(3):405\u2013414","DOI":"10.1111\/jdv.12772"},{"key":"4673_CR8","doi-asserted-by":"crossref","unstructured":"Horv\u00e1th O, Borovaya A, Roider E, Klose J, Hartlieb E, Waschke J et al (2015) Successful methotrexate treatment of oesophageal pemphigus vulgaris in an immunosuppressed patient with Crohn\u2019s disease. Acta Derm Venereol 95(7):868\u2013869","DOI":"10.2340\/00015555-2070"},{"key":"4673_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/MEG.0000000000001140","volume":"30","author":"K Kridin","year":"2018","unstructured":"Kridin K, Comaneshter D, Cohen AD (2018) Short article: Crohn\u2019s disease and pemphigus: is there an association?: a population-based study. Eur J Gastroenterol Hepatol 30:727\u2013729","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4673_CR10","first-page":"168","volume":"25","author":"L Castain","year":"2021","unstructured":"Castain L, Bressollette-Bodin C (2021) Viral reactivations in intensive care unit: biomarkers of immune dysfunction or true pathogens? Virol Montrouge Fr 25:168\u2013182","journal-title":"Virol Montrouge Fr"},{"key":"4673_CR11","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1177\/039463200902200324","volume":"22","author":"AV Marzano","year":"2009","unstructured":"Marzano AV, Tourlaki A, Merlo V, Spinelli D, Venegoni L, Crosti C (2009) Herpes simplex virus infection and pemphigus. Int J Immunopathol Pharmacol 22:781\u2013786","journal-title":"Int J Immunopathol Pharmacol"},{"key":"4673_CR12","doi-asserted-by":"crossref","unstructured":"Baum S, Atar I, Coster D, Dovrat S, Solomon M, Sprecher E et al (2022) Relationship between pemphigus vulgaris severity and PCR-positive herpes simplex virus. Acta Derm Venereol 102:adv00703","DOI":"10.2340\/actadv.v102.917"},{"key":"4673_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1159\/000365845","volume":"229","author":"E Ruocco","year":"2014","unstructured":"Ruocco E, Ruocco V, Lo Schiavo A, Brunetti G, Wolf R (2014) Viruses and pemphigus: an intriguing never-ending story. Dermatology 229:310\u2013315","journal-title":"Dermatology"},{"key":"4673_CR14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/exd.12229","volume":"22","author":"KT Amber","year":"2013","unstructured":"Amber KT, Staropoli P, Shiman MI, Elgart GW, Hertl M (2013) Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris. Exp Dermatol 22:699\u2013704","journal-title":"Exp Dermatol"},{"key":"4673_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00403-017-1790-8","volume":"310","author":"S Tavakolpour","year":"2018","unstructured":"Tavakolpour S (2018) Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus. Arch Dermatol Res 310:95\u2013106","journal-title":"Arch Dermatol Res"},{"key":"4673_CR16","unstructured":"Abbas AK, Lichtman AH, Pillai S\u00a0(2017) Cellular and molecular immunology, 9th edn. Philadelphia, PA, Elsevier"},{"key":"4673_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/ijd.13577","volume":"56","author":"JM Gil","year":"2017","unstructured":"Gil JM, Weber R, Rosales CB, Rodrigues H, Sennes LU, Kalil J et al (2017) Study of the association between human leukocyte antigens (HLA) and pemphigus vulgaris in Brazilian patients. Int J Dermatol 56:557\u2013562","journal-title":"Int J Dermatol"},{"key":"4673_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.dib.2016.05.077","volume":"8","author":"MJ Franco Brochado","year":"2016","unstructured":"Franco Brochado MJ, Nascimento DF, SaloumDeghaide NH, Donadi EA, Roselino AM (2016) Data on HLA class I\/II profile in Brazilian pemphigus patients. Data Brief 8:364\u2013374","journal-title":"Data Brief"},{"key":"4673_CR19","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/ijd.13714","volume":"56","author":"BS Celere","year":"2017","unstructured":"Celere BS, Vernal S, Brochado MJF, Segura-Mu\u00f1oz SI, Roselino AM (2017) Geographical foci and epidemiological changes of pemphigus vulgaris in four decades in Southeastern Brazil. Int J Dermatol 56:1494\u20131496","journal-title":"Int J Dermatol"},{"key":"4673_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.clindermatol.2011.01.016","volume":"29","author":"S Brenner","year":"2011","unstructured":"Brenner S, Goldberg I (2011) Drug-induced pemphigus. Clin Dermatol 29:455\u2013457","journal-title":"Clin Dermatol"},{"key":"4673_CR21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1468-3083.2008.02929.x","volume":"23","author":"S Daulat","year":"2009","unstructured":"Daulat S, Detweiler J, Pandya A (2009) Development of pemphigus vulgaris in a patient with psoriasis treated with etanercept. J Eur Acad Dermatol Venereol 23:483\u2013484","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4673_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000111506","volume":"216","author":"S Morell-Dubois","year":"2008","unstructured":"Morell-Dubois S, Carpentier O, Cottencin O, Queyrel V, Hachulla E, Hatron P-Y et al (2008) Stressful life events and pemphigus. Dermatology 216:104\u2013108","journal-title":"Dermatology"},{"key":"4673_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/aje\/155.3.249","volume":"155","author":"S Bastuji-Garin","year":"2002","unstructured":"Bastuji-Garin S, Turki H, Mokhtar I, Nouira R, Fazaa B, Jomaa B et al (2002) Possible relation of Tunisian pemphigus with traditional cosmetics: a multicenter case-control study. Am J Epidemiol 155:249\u2013256","journal-title":"Am J Epidemiol"},{"key":"4673_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1525-1470.1994.tb00569.x","volume":"11","author":"JS Prendiville","year":"1994","unstructured":"Prendiville JS, Israel DM, Wood WS, Dimmick JE (1994) Oral pemphigus vulgaris associated with inflammatory bowel disease and herpetic gingivostomatitis in an 11-year-old girl. Pediatr Dermatol 11:145\u2013150","journal-title":"Pediatr Dermatol"},{"key":"4673_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13062-020-00280-5","volume":"15","author":"L Petagna","year":"2020","unstructured":"Petagna L, Antonelli A, Ganini C, Bellato V, Campanelli M, Divizia A et al (2020) Pathophysiology of Crohn\u2019s disease inflammation and recurrence. Biol Direct 15:23","journal-title":"Biol Direct"},{"key":"4673_CR26","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.cgh.2022.07.032","volume":"21","author":"V Solitano","year":"2023","unstructured":"Solitano V, Facciorusso A, Jess T, Ma C, Hassan C, Repici A et al (2023) Comparative risk of serious infections with biologic agents and oral small molecules in inflammatory bowel diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 21:907-921.e2","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4673_CR27","doi-asserted-by":"crossref","unstructured":"Singh S, Kim J, Luo J, Paul P, Rudrapatna V, Park S et al (2023) Comparative safety and effectiveness of biologic therapy for Crohn\u2019s disease: a CA-IBD cohort study.\u00a0Clin Gastroenterol Hepatol\u00a021:2359\u20132369.e5","DOI":"10.1016\/j.cgh.2022.10.029"},{"key":"4673_CR28","doi-asserted-by":"publisher","first-page":"175628482311594","DOI":"10.1177\/17562848231159452","volume":"16","author":"B Bressler","year":"2023","unstructured":"Bressler B (2023) Is there an optimal sequence of biologic therapies for inflammatory bowel disease? Ther Adv Gastroenterol 16:17562848231159452","journal-title":"Ther Adv Gastroenterol"},{"key":"4673_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","volume":"14","author":"J Torres","year":"2020","unstructured":"Torres J, Bonovas S, Doherty G, Kucharzik T, Gisbert JP, Raine T et al (2020) ECCO guidelines on therapeutics in Crohn\u2019s disease: medical treatment. J Crohns Colitis 14:4\u201322","journal-title":"J Crohns Colitis"},{"key":"4673_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1046\/j.1523-1747.2000.00835.x","volume":"114","author":"C Feliciani","year":"2000","unstructured":"Feliciani C, Toto P, Amerio P, Pour SM, Coscione G, Shivji G et al (2000) In vitro and in vivo expression of interleukin-1alpha and tumor necrosis factor-alpha mRNA in pemphigus vulgaris: interleukin-1alpha and tumor necrosis factor-alpha are involved in acantholysis. J Invest Dermatol 114:71\u201377","journal-title":"J Invest Dermatol"},{"key":"4673_CR31","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/bjd.13823","volume":"173","author":"RJ Feldman","year":"2015","unstructured":"Feldman RJ (2015) Paradoxical worsening of pemphigus vulgaris following rituximab therapy. Br J Dermatol 173:858\u2013859","journal-title":"Br J Dermatol"},{"key":"4673_CR32","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1097\/MEG.0000000000001918","volume":"32","author":"W Sbeit","year":"2020","unstructured":"Sbeit W, Kadah A, Mahamid M, Karayanni H, Mari A, Tali S et al (2020) Oral manifestations of inflammatory bowel disease: the neglected piece of the puzzle. Eur J Gastroenterol Hepatol 32:1422\u20131431","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4673_CR33","doi-asserted-by":"crossref","unstructured":"Stein\u00a0RB, Hanauer SB (2000) Comparative tolerability of treatments for inflammatory bowel disease. Drug Saf 23:429\u2013448","DOI":"10.2165\/00002018-200023050-00006"},{"key":"4673_CR34","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1053\/j.gastro.2008.01.012","volume":"134","author":"M Toruner","year":"2008","unstructured":"Toruner M, Loftus EV, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ et al (2008) Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 134:929\u2013936","journal-title":"Gastroenterology"},{"key":"4673_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaad.2008.09.032","volume":"61","author":"A Asarch","year":"2009","unstructured":"Asarch A, Gottlieb AB, Lee J, Masterpol KS, Scheinman PL, Stadecker MJ et al (2009) Lichen planus\u2013like eruptions: an emerging side effect of tumor necrosis factor-\u03b1 antagonists. J Am Acad Dermatol 61:104\u2013111","journal-title":"J Am Acad Dermatol"},{"key":"4673_CR36","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1053\/j.gastro.2007.01.014","volume":"132","author":"AC Moss","year":"2007","unstructured":"Moss AC, Treister NS, Marsee DK, Cheifetz AS (2007) Clinical challenges and images in GI. Gastroenterology 132:488\u2013829","journal-title":"Gastroenterology"},{"key":"4673_CR37","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nrrheum.2011.35","volume":"7","author":"JC Prinz","year":"2011","unstructured":"Prinz JC (2011) Autoimmune-like syndromes during TNF blockade: does infection have a role? Nat Rev Rheumatol 7:429\u2013434","journal-title":"Nat Rev Rheumatol"},{"key":"4673_CR38","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1016\/j.oooo.2012.08.001","volume":"115","author":"D Edwards","year":"2013","unstructured":"Edwards D, Boritz E, Cowen EW, Brown RS (2013) Erythema multiforme major following treatment with infliximab. Oral Surg Oral Med Oral Pathol Oral Radiol 115:e36-40","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"4673_CR39","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/jdv.16752","volume":"34","author":"P Joly","year":"2020","unstructured":"Joly P, Horvath B, Patsatsi \u0391, Uzun S, Bech R, Beissert S et al (2020) Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol 34:1900\u20131913","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4673_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1517\/14740338.2016.1112375","volume":"15","author":"G Murdaca","year":"2016","unstructured":"Murdaca G, Span\u00f2 F, Contatore M, Guastalla A, Penza E, Magnani O et al (2016) Immunogenicity of infliximab and adalimumab: what is its role in hypersensitivity and modulation of therapeutic efficacy and safety? Expert Opin Drug Saf 15:43\u201352","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"4673_CR41","first-page":"659","volume":"60","author":"SM Cazacu","year":"2019","unstructured":"Cazacu SM, Ghilu M-C, Ivan ET, Ungureanu BS, Ciurea T, For M (2019) An unusual onset of Crohn\u2019s disease with oral aphthosis, giant esophageal ulcers and serological markers of cytomegalovirus and herpes virus infection: a case report and review of the literature. Rom J Morphol Embryol 60(2):659\u2013665","journal-title":"Rom J Morphol Embryol"},{"key":"4673_CR42","doi-asserted-by":"publisher","first-page":"252","DOI":"10.5009\/gnl.2013.7.2.252","volume":"7","author":"W Kim","year":"2013","unstructured":"Kim W, Kang B, Kim B-W, Kim JS, Lee H-M, Lim E-J et al (2013) Crohn\u2019s disease initially accompanied by deep vein thrombosis and ulnar neuropathy without metronidazole exposure. Gut Liver 7:252\u2013254","journal-title":"Gut Liver"},{"key":"4673_CR43","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/gut.2003.025411","volume":"53","author":"W Miehsler","year":"2004","unstructured":"Miehsler W, Reinisch W, Valic E, Osterode W, Tillinger W, Feichtenschlager T et al (2004) Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 53:542\u2013548","journal-title":"Gut"},{"key":"4673_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.7547\/17-108","volume":"109","author":"DG Dimond","year":"2019","unstructured":"Dimond DG, Lam JK, Wurster L, Kiser C, Driscoll K, Razzante M (2019) The solitary blue toe: a unique presentation of antiphospholipid syndrome. J Am Podiatr Med Assoc 109:235\u2013240","journal-title":"J Am Podiatr Med Assoc"},{"key":"4673_CR45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.15171\/jlms.2017.32","volume":"8","author":"M Yousef","year":"2017","unstructured":"Yousef M, Mansouri P, Partovikia M, Esmaili M, Younespour S, Hassani L (2017) The effect of low level laser therapy on pemphigus vulgaris lesions: a pilot study. J Lasers Med Sci 8:177\u2013180","journal-title":"J Lasers Med Sci"},{"key":"4673_CR46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2298\/MPNS1402038P","volume":"67","author":"V Pavli\u0107","year":"2014","unstructured":"Pavli\u0107 V, Aleksi\u0107 VV, Zubovi\u0107 N, Veselinovi\u0107 V (2014) Pemphigus vulgaris and laser therapy: crucial role of dentists. Med Pregl 67:38\u201342","journal-title":"Med Pregl"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-024-04673-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-024-04673-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-024-04673-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T17:09:29Z","timestamp":1722964169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-024-04673-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4673"],"URL":"https:\/\/doi.org\/10.1007\/s00384-024-04673-0","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]},"assertion":[{"value":"17 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This report was made in accordance with the CARE guideline standards ().","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for this case report was provided by the Ethical Committee of the School of Medicine, Federal Fluminense University, under number 6.738.011.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The participant has consented to the submission of the case report to the journal and signed the consent inform.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}